시장보고서

상품코드

1553511

치료제 모니터링 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 약제 클래스별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Therapeutic Drug Monitoring Market Size, Share & Trends Analysis Report By Product (Equipment, Consumables), By Drug Class (Antiarrhythmic Drugs), By End Use (Diagnostic Centers), By Region, And Segment Forecasts, 2024 - 2030

발행일: 2024년 08월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

치료제 모니터링 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 치료제 모니터링 시장 규모는 2024-2030년 CAGR 3.8%로 확대하며, 2030년에는 23억 2,000만 달러에 달할 것으로 추정되고 있습니다.

Point-of-Care(PoC) 디바이스의 최근 기술 발전은 개인화된 예측 의료와 예방 의료에 큰 변화를 가져올 수 있는 잠재력을 가지고 있습니다. 치료제물 모니터링(TDM)은 환자 맞춤형 치료 계획을 수립하기 위한 기초적인 부분을 형성하고 있으며, 약물 농도를 정량적으로 측정할 수 있는 PoC 진단 기기의 등장은 헬스케어 분야의 정밀의료 분야 발전을 지원하는 매우 중요한 역할을 하고 있습니다. 그러나 환자 모니터링에 대한 PoC 디바이스의 광범위한 적용은 아직 미진합니다. 이러한 미개척 기회의 존재는 시장 성장에 큰 영향을 미치는 촉진제 중 하나입니다.

장기 이식 후 투여되는 약물 요법의 초기 단계에서 지속적인 치료 약물 및 대사산물 모니터링의 채택은 중증 환자 치료 및 장기 이식 분야에서 주요 용도를 형성하고 있으며, 예측 기간 중 치료 약물 모니터링 시장의 성장을 가속할 것으로 예상됩니다. 시장 성장을 가속할 것으로 예상됩니다. 또한 간질 및 암과 같은 질병 부담 증가, 정부 구상 증가, 미충족 수요 증가는 이 시장의 출현을 더욱 촉진할 것으로 예상되는 중요한 결정 요인 중 일부입니다.

치료제 모니터링 시장 보고서 하이라이트

소모품 부문은 2023년 시장 점유율의 65.4% 이상을 차지했습니다. 이는 실험실에서 소모품에 대한 광범위한 요구 사항과 키트 및 시약의 반복 구매로 인한 결과입니다.
면역억제제 부문은 예측 기간 중 연평균 5.3%의 복합 성장률로 가장 빠르게 성장할 것으로 예상됩니다.
2023년 시장 점유율은 병원 부문이 압도적이었습니다. 대형 병원에서는 면역 분석을 수행하기 위해 다양한 기초 기술을 채택하고 있습니다. 여기에는 화학 발광, 네페로메트리, 비색, 형광 등이 포함되며, 다양한 약물 패널을 검사하는 데 사용할 수 있습니다.
면역억제제 치료제 모니터링은 투여된 면역억제제 및 그 대사산물의 농도를 평가하기 위한 새로운 TDM 현장 검사 장비의 도입으로 가장 빠르게 성장하고 있는 용도 중 하나입니다.

치료제 모니터링 시장 점유율, 지역별, 2024년 및 2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제8장 경쟁 구도

주요 시장 참여 기업에 의한 최근 동향과 영향 분석
기업 분류
기업 히트맵 분석
기업 개요
- Abbott
- ALPCO
- Beckman Coulter, Inc
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Chromsystems Instruments &Chemicals GmbH
- F.Hoffmann-La Roche Ltd.
- Randox laboratories Ltd
- Siemens Healthineers AG.
- biomerieux, Inc.

KSA 24.09.25

Therapeutic Drug Monitoring Market Growth & Trends:

The global therapeutic drug monitoring market size is estimated to reach USD 2.32 billion by 2030, expanding at a CAGR of 3.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Recent technological advancements in the Point-of-Care (PoC) devices hold considerable transformative promises for the personalized predictive and preventive medicine. Therapeutic Drug Monitoring (TDM) forms a foundational part to the devising of personalized treatment plans for patients; and the advent of PoC diagnostic devices that yield quantitative measurements of the drug concentration plays a pivotal role in supporting the development of the precision medicine field in the healthcare sector. However, the broad application of the PoC devices for patient monitoring is still lagging behind. The presence of this untapped opportunity is one of the high impact rendering drivers for the market growth.

The employment of continuous therapeutic drug and metabolite monitoring in the early phase of the medication regimen, administered post-organ transplantation, forms a major application in the areas of critical care medicine and organ transplantation, which is expected to propel the growth of the therapeutic drug monitoring market over the forecast period. In addition, the imposing burden of diseases, such as epilepsy and cancer, the rising government initiatives, and the presence of high-unmet needs are some of the crucial determinants expected to further favor the emergence of this market.

Therapeutic Drug Monitoring Market Report Highlights:

The consumables segment covered over 65.4% of the market share in 2023 as a consequence of the extensive requirement of the consumables in the research laboratories and due to the repeat purchase of the kits and reagents.
The immunosuppressants segment is expected to grow fastest, with a compounded annual growth rate of 5.3% over the forecast period.
The hospital segment dominated the market share in 2023. In larger hospitals, various underlying technologies are employed to perform immunoassays; these comprise chemiluminescence, nephelometry, colorimetry, and fluorescence, which are available for the testing of a wide ranging drug panel.
The drug monitoring for the immunosuppressants is one of the fastest growing application segments owing to the introduction of novel TDM point-of-care testing devices for the evaluation of the concentration of administered immunosuppressants and the complementary metabolites, in order to achieve a prominent therapeutic effect while preventing drug toxicity events in patients that have undergone transplantations.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Therapeutic Drug Monitoring Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Therapeutic Drug Monitoring Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Therapeutic Drug Monitoring Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Therapeutic Drug Monitoring Market: Product Movement Analysis, 2024 & 2030 (USD Million)
4.3. Equipment
- 4.3.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.2. Immunoassay Analyzers
  - 4.3.2.1. Immunoassay Analyzers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.3. Clinical Chemistry Analyzers
  - 4.3.3.1. Clinical Chemistry Analyzers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.4. Chromatography & MS detectors
  - 4.3.4.1. Chromatography & MS detectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Consumables
- 4.4.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Therapeutic Drug Monitoring Market: Drug Class Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Therapeutic Drug Monitoring Market: Drug Class Movement Analysis, 2024 & 2030 (USD Million)
5.3. Antiarrhythmic Drugs
- 5.3.1. Antiarrhythmic Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Immunosuppressants
- 5.4.1. Immunosuppressants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Antiepileptic Drugs
- 5.5.1. Antiepileptic Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
- 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Therapeutic Drug Monitoring Market: End Use Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Therapeutic Drug Monitoring Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
6.3. Hospitals
- 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Diagnostic Centers
- 6.4.1. Diagnostics Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
- 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Therapeutic Drug Monitoring Market: Regional Estimates & Trend Analysis

7.1. Therapeutic Drug Monitoring Market Share, By Region, 2024 & 2030 (USD Million)
7.2. North America
- 7.2.1. North America Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
  - 7.2.2.1. U.S. Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Canada
  - 7.2.3.1. Canada Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.4. Mexico
  - 7.2.4.1. Mexico Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
- 7.3.1. Europe Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. UK
  - 7.3.2.1. UK Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Germany
  - 7.3.3.1. Germany Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. France
  - 7.3.4.1. France Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.5. Italy
  - 7.3.5.1. Italy Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.6. Spain
  - 7.3.6.1. Spain Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.7. Denmark
  - 7.3.7.1. Denmark Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.8. Sweden
  - 7.3.8.1. Sweden Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.9. Norway
  - 7.3.9.1. Norway Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
- 7.4.1. Asia Pacific Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. Japan
  - 7.4.2.1. Japan Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. China
  - 7.4.3.1. China Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. India
  - 7.4.4.1. India Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. Australia
  - 7.4.5.1. Australia Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. South Korea
  - 7.4.6.1. South Korea Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Thailand
  - 7.4.7.1. Thailand Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
- 7.5.1. Latin America Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
  - 7.5.2.1. Brazil Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Argentina
  - 7.5.3.1. Argentina Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
- 7.6.1. Middle East and Africa Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. South Africa
  - 7.6.2.1. South Africa Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Saudi Arabia
  - 7.6.3.1. Saudi Arabia Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. UAE
  - 7.6.4.1. UAE Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
  - 7.6.5.1. Kuwait Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
- 8.4.1. Abbott
  - 8.4.1.1. Participant's Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Recent Developments/ Strategic Initiatives
- 8.4.2. ALPCO
  - 8.4.2.1. Participant's Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Recent Developments/ Strategic Initiatives
- 8.4.3. Beckman Coulter, Inc
  - 8.4.3.1. Participant's Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Recent Developments/ Strategic Initiatives
- 8.4.4. Bio-Rad Laboratories, Inc.
  - 8.4.4.1. Participant's Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Recent Developments/ Strategic Initiatives
- 8.4.5. Thermo Fisher Scientific Inc.
  - 8.4.5.1. Participant's Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Recent Developments/ Strategic Initiatives
- 8.4.6. Chromsystems Instruments & Chemicals GmbH
  - 8.4.6.1. Participant's Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Recent Developments/ Strategic Initiatives
- 8.4.7. F.Hoffmann-La Roche Ltd.
  - 8.4.7.1. Participant's Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Recent Developments/ Strategic Initiatives
- 8.4.8. Randox laboratories Ltd
  - 8.4.8.1. Participant's Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Recent Developments/ Strategic Initiatives
- 8.4.9. Siemens Healthineers AG.
  - 8.4.9.1. Participant's Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Recent Developments/ Strategic Initiatives
- 8.4.10. biomerieux, Inc.
  - 8.4.10.1. Participant's Overview
  - 8.4.10.2. Financial Performance
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Recent Developments/ Strategic Initiatives

치료제 모니터링 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 약제 클래스별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Therapeutic Drug Monitoring Market Size, Share & Trends Analysis Report By Product (Equipment, Consumables), By Drug Class (Antiarrhythmic Drugs), By End Use (Diagnostic Centers), By Region, And Segment Forecasts, 2024 - 2030

치료제 모니터링 시장의 성장과 동향 :

치료제 모니터링 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 개요

제3장 치료제 모니터링 시장의 변수, 동향, 범위

제4장 치료제 모니터링 시장 : 제품별 추정·동향 분석

제5장 치료제 모니터링 시장 : 약제 클래스별 추정·동향 분석

제6장 치료제 모니터링 시장 : 최종 용도별 추정·동향 분석

제7장 치료제 모니터링 시장 : 지역별 추정·동향 분석